Literature DB >> 4054162

Investigation of serum bile acids; seven patients with Alagille syndrome.

K Obinata, N Nakatsu, T Watanabe, S Niijima, O Arisaka, H Sasaki, H Nittono, K Yabuta, T Miyano.   

Abstract

To clarify whether an abnormal bile acid pattern has a role in the pathogenesis of Alagille syndrome, we compared serum bile acid patterns in seven with Alagille syndrome with those of patients with congenital biliary atresia (CBA), neonatal hepatitis (NH) and normal infants. Of the seven patients with Alagille syndrome, four patients were younger and three were older than 1 year. The mean total serum bile acid level in the infants was higher than in older subjects. There was a dissociation between the levels of serum total bile acid and bilirubin in three of the seven cases. The mean total bile acid levels in serum were in the following decreasing order: CBA, Alagille syndrome, NH and controls. The ratio of cholate to chenodeoxycholate in the younger patients with Alagille syndrome was significantly higher than CBA (P less than 0.001). However, no specific bile acid pattern was found in Alagille syndrome by high-performance liquid chromatography (HPLC).

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4054162     DOI: 10.1007/BF00451949

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  14 in total

1.  Arteriohepatic dysplasia: familial pulmonary arterial stenosis with neonatal liver disease.

Authors:  G H Watson; V Miller
Journal:  Arch Dis Child       Date:  1973-06       Impact factor: 3.791

2.  Byler's disease: fatal intrahepatic cholestasis.

Authors:  L G Linarelli; C N Williams; M J Phillips
Journal:  J Pediatr       Date:  1972-09       Impact factor: 4.406

3.  Hereditary cholestasis combined with peripheral pulmonary stenosis and other anomalies.

Authors:  N T Henriksen; F Langmark; S J Sorland; O Fausa; S Landaas; O Aagenaes
Journal:  Acta Paediatr Scand       Date:  1977-01

4.  Alpha1-antitrypsin deficiency and liver disease in children: phenotypes, manifestations, and prognosis.

Authors:  M Odièvre; J P Martin; M Hadchouel; D Alagille
Journal:  Pediatrics       Date:  1976-02       Impact factor: 7.124

5.  The metabolism of 3alpha, 7alpha, 12alpha-trihydorxy-5beta-cholestan-26-oic acid in two siblings with cholestasis due to intrahepatic bile duct anomalies. An apparent inborn error of cholic acid synthesis.

Authors:  R F Hanson; J N Isenberg; G C Williams; D Hachey; P Szczepanik; P D Klein; H L Sharp
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

6.  Intrahepatic cholestasis in childhood.

Authors:  J Heathcote; K P Deodhar; P J Scheuer; S Sherlock
Journal:  N Engl J Med       Date:  1976-10-07       Impact factor: 91.245

7.  Hepatic ductular hypoplasia associated with characteristic facies, vertebral malformations, retarded physical, mental, and sexual development, and cardiac murmur.

Authors:  D Alagille; M Odièvre; M Gautier; J P Dommergues
Journal:  J Pediatr       Date:  1975-01       Impact factor: 4.406

8.  High performance liquid-chromatographic analysis of individual bile acids: free, glycine- and taurine-conjugated bile acids.

Authors:  S Okuyama
Journal:  Gastroenterol Jpn       Date:  1979

9.  Bile acid metabolism in mild arteriohepatic dysplasia.

Authors:  D M Collins; F T Shannon; C B Campbell
Journal:  Aust N Z J Med       Date:  1981-02

10.  Arteriohepatic dysplasia: association of liver disease with pulmonary arterial stenosis as well as facial and skeletal abnormalities.

Authors:  S E Levin; P Zarvos; S Milner; A Schmaman
Journal:  Pediatrics       Date:  1980-12       Impact factor: 7.124

View more
  2 in total

1.  Paucity of intrahepatic bile ducts, solitary kidney and atrophic pancreas with diabetes mellitus: atypical Alagille syndrome?

Authors:  K Devriendt; L Dooms; W Proesmans; F de Zegher; V Desmet; E Eggermont
Journal:  Eur J Pediatr       Date:  1996-02       Impact factor: 3.183

Review 2.  The Alagille syndrome (arteriohepatic dysplasia).

Authors:  R F Mueller
Journal:  J Med Genet       Date:  1987-10       Impact factor: 6.318

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.